APA (7th ed.) Citation

CC, M., EN, M., GH, L., T, O., J, L., WM, S., . . . Scheld, W. M. (2008). An A2A adenosine receptor agonist, ATL313, reduces inflammation and improves survival in murine sepsis models. BMC Infectious Diseases, 8(1), 141. https://doi.org/10.1186/1471-2334-8-141

Chicago Style (17th ed.) Citation

CC, Moore, et al. "An A2A Adenosine Receptor Agonist, ATL313, Reduces Inflammation and Improves Survival in Murine Sepsis Models." BMC Infectious Diseases 8, no. 1 (2008): 141. https://doi.org/10.1186/1471-2334-8-141.

MLA (9th ed.) Citation

CC, Moore, et al. "An A2A Adenosine Receptor Agonist, ATL313, Reduces Inflammation and Improves Survival in Murine Sepsis Models." BMC Infectious Diseases, vol. 8, no. 1, 2008, p. 141, https://doi.org/10.1186/1471-2334-8-141.